IL36G and neoplasm: IL-36γ expression is found to correlate with the number of tumor-infiltrating lymphocytes such as CD8+, NK, and γδT cells, and the adaptive tumor antigen-specific CD8+ T cell immune response is enhanced by IL-36γ (Wang et al., 2015), which further corroborates its anti-tumor activity.